|
1
|
Jelic S and Sotiropoulos GC; ESMO
Guidelines Working Group. Hepatocellular carcinoma: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21:v59–v64. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang JD and Roberts LR: Hepatocellular
carcinoma: a global view. Nat Rev Gastroenterol Hepatol. 7:448–458.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McGlynn KA and London WT: International
liver cancer incidence trends - letter. Cancer Epidemiol Biomarkers
Prev. 21:384–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Venook AP, Papandreou C, Furuse J and de
Guevara LL: The incidence and epidemiology of hepatocellular
carcinoma: a global and regional perspective. Oncologist. 15:5–13.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sarkar D, Boukerche H, Su Z-Z and Fisher
PB: mda-9/syntenin: recent insights into a novel cell
signaling and metastasis-associated gene. Pharmacol Ther.
104:101–115. 2004. View Article : Google Scholar
|
|
7
|
Das SK, Bhutia SK, Sokhi UK, et al: Raf
kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis
in melanoma. Cancer Res. 72:6217–6226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu Y and Schachner M: Syntenin-a promotes
spinal cord regeneration following injury in adult zebrafish. Eur J
Neurosci. 38:2280–2289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gangemi R, Mirisola V, Barisione G, et al:
Mda-9/syntenin is expressed in uveal melanoma and correlates with
metastatic progression. PLoS One. 7:e299892012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Y, Hong Q, Shi P, Liu Z, Luo J and
Shao Z: Elevated expression of syntenin in breast cancer is
correlated with lymph node metastasis and poor patient survival.
Breast Cancer Res. 15:R502013. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Das SK, Bhutia SK, Kegelman TP, et al:
MDA-9/syntenin: a positive gatekeeper of melanoma metastasis. Front
Biosci. 17:1–15. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Boukerche H, Su ZZ, Prévot C, Sarkar D and
Fisher PB: mda-9/syntenin promotes metastasis in human
melanoma cells by activating c-Src. Proc Natl Acad Sci.
105:15914–15919. 2008. View Article : Google Scholar
|
|
13
|
Koo TH, Lee JJ, Kim EM, Kim KW, Kim HD and
Lee JH: Syntenin is overexpressed and promotes cell migration in
meta-static human breast and gastric cancer cell lines. Oncogene.
21:4080–4088. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dasgupta S, Menezes ME, Das SK, et al:
Novel role of MDA-9/syntenin in regulating urothelial cell
proliferation by modulating EGFR signaling. Clin Cancer Res.
19:4621–4633. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han W, Pan H, Chen Y, et al: EGFR tyrosine
kinase inhibitors activate autophagy as a cytoprotective response
in human lung cancer cells. PLoS One. 6:e186912011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Spano J, Fagard R, Soria JC, Rixe O,
Khayat D and Milano G: Epidermal growth factor receptor signaling
in colorectal cancer: preclinical data and therapeutic
perspectives. Ann Oncol. 16:189–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kannangai R, Sahin F and Torbenson MS:
EGFR is phosphorylated at Ty845 in hepatocellular carcinoma. Mod
Pathol. 19:1456–1461. 2006.PubMed/NCBI
|
|
18
|
Mitsudomi T and Yatabe Y: Epidermal growth
factor receptor in relation to tumor development: EGFR gene
and cancer. FEBS J. 277:301–308. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang X, Lu N, Niu B, Chen X, Xie J and
Cheng N: Overexpression of Aurora-A enhances invasion and matrix
metalloproteinase-2 expression in esophageal squamous cell
carcinoma cells. Mol Cancer Res. 10:588–596. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim H and Lim HY: Novel EGFR-TK inhibitor
EKB-569 inhibits hepatocellular carcinoma cell proliferation by AKT
and MAPK pathways. J Korean Med Sci. 26:1563–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Boukerche H, Aissaoui H, Prévost C, et al:
OC-13 enhanced expression of Mda-9/syntenin induced through the
tissue-factor pathway in melanoma promotes tumor cell migration and
invasion. Thromb Res. 125(Suppl 2): S1642010. View Article : Google Scholar
|
|
22
|
Kim WY, Jang JY, Jeon YK, Chung DH, Kim YG
and Kim CW: Syntenin increases the invasiveness of small cell lung
cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
Exp Mol Med. 46:e902014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bazley LA and Gullick WJ: The epidermal
growth factor receptor family. Endocr Relat Cancer. 12(Suppl 12):
S17–S27. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
da Cunha Santos G, Shepherd FA and Tsao
MS: EGFR mutations and lung cancer. Annu Rev Pathol. 6:49–69.
2011.
|
|
25
|
Hirsch FR, Varella-Garcia M and Cappuzzo
F: Predictive value of EGFR and HER2 overexpression in advanced
non-small-cell lung cancer. Oncogene. 28:S32–S37. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nicholson RI, Gee JM and Harper ME: EGFR
and cancer prognosis. Eur J Cancer. 37:9–15. 2001. View Article : Google Scholar
|
|
27
|
Duffy MJ, McGowan PM and Gallagher WM:
Cancer invasion and metastasis: changing views. J Pathol.
214:283–293. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lara-Pezzi E, Gómez-Gaviro MV, Gálvez BG,
et al: The hepatitis B virus X protein promotes tumor cell invasion
by inducing membrane-type matrix metalloproteinase-1 and
cyclooxygenase-2 expression. J Clin Invest. 110:1831–1838. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giannelli G, Bergamini C, Marinosci F, et
al: Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular
carcinoma. Int J Cancer. 97:425–431. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
del Barco Barrantes I and Nebreda A: Roles
of p38 MAPKs in invasion and metastasis. Biochem Soc Trans.
40:79–84. 2012.PubMed/NCBI
|
